|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-14
|
|
pubmed:abstractText |
High-grade astrocytomas (HGA) carry a dismal prognosis and compose nearly 20% of all childhood brain tumors. The role of high-dose chemotherapy (HDCT) in the treatment of HGA remains unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:ArensonEdward BEB,
pubmed-author:AterJoannJ,
pubmed-author:BevanHerbert EHE,
pubmed-author:BrunerJanetJ,
pubmed-author:DeutschMelvinM,
pubmed-author:HolmesEmiE,
pubmed-author:KurczynskiElizabethE,
pubmed-author:LuerssenThomasT,
pubmed-author:MacDonaldTobey JTJ,
pubmed-author:McGuire-CullenPatriciaP,
pubmed-author:O'BrienRichardR,
pubmed-author:PackerRogerR,
pubmed-author:PhillipsPeterP,
pubmed-author:ShahNarayanN,
pubmed-author:SpostoRichardR,
pubmed-author:SteinbokPaulP,
pubmed-author:StrainJohnJ,
pubmed-author:ThomsonJohnJ,
pubmed-author:VezinaGilbertG,
pubmed-author:YatesAllanA
|
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2862-71
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:16315242-Adolescent,
pubmed-meshheading:16315242-Adult,
pubmed-meshheading:16315242-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16315242-Brain Stem Neoplasms,
pubmed-meshheading:16315242-Child,
pubmed-meshheading:16315242-Child, Preschool,
pubmed-meshheading:16315242-Combined Modality Therapy,
pubmed-meshheading:16315242-Disease-Free Survival,
pubmed-meshheading:16315242-Dose-Response Relationship, Drug,
pubmed-meshheading:16315242-Drug Administration Schedule,
pubmed-meshheading:16315242-Female,
pubmed-meshheading:16315242-Glioblastoma,
pubmed-meshheading:16315242-Humans,
pubmed-meshheading:16315242-Male,
pubmed-meshheading:16315242-Neoadjuvant Therapy,
pubmed-meshheading:16315242-Neoplasm Staging,
pubmed-meshheading:16315242-Probability,
pubmed-meshheading:16315242-Prognosis,
pubmed-meshheading:16315242-Prospective Studies,
pubmed-meshheading:16315242-Radiotherapy, High-Energy,
pubmed-meshheading:16315242-Reference Values,
pubmed-meshheading:16315242-Risk Assessment,
pubmed-meshheading:16315242-Spinal Cord Neoplasms,
pubmed-meshheading:16315242-Survival Analysis,
pubmed-meshheading:16315242-Time Factors,
pubmed-meshheading:16315242-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
|
|
pubmed:affiliation |
Department of Hematology-Oncology, Children's National Medical Center, Washington, DC 20010, USA. tmacdona@cnmc.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
